Jacqueline C. Barrientos
Mount Sinai Medical Center(US)Sylvester Comprehensive Cancer Center(US)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Immunodeficiency and Autoimmune Disorders, Chronic Myeloid Leukemia Treatments, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia(2014)1,675 cited
- → Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma(2013)1,668 cited
- → Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia(2014)1,603 cited
- → Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib(2014)1,240 cited
- → Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma(2015)1,102 cited
- → Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia(2015)881 cited
- → Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia(2019)722 cited